Tonix Pharmaceuticals Holding Stock Investor Sentiment
| TNXP Stock | USD 30.51 7.48 32.48% |
Slightly above 57% of all Tonix Pharmaceuticals' retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Tonix Pharmaceuticals Holding suggests that some traders are interested. Tonix Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Tonix Pharmaceuticals Holding. Many technical investors use Tonix Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 57
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Tonix Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Tonix Pharmaceuticals Holding.
News SentimentBearish | Hype SentimentNeutral | Insider SentimentAcquiring |
Tonix Historical Sentiment
Although Tonix Pharmaceuticals' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Tonix, such as negative comments on social media and news outlets, may cause fear in the market and push Tonix Pharmaceuticals' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Tonix.
Tonix |
Tonix Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tonix Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Tonix Pharmaceuticals Historical Investor Sentiment
Investor biases related to Tonix Pharmaceuticals' public news can be used to forecast risks associated with an investment in Tonix. The trend in average sentiment can be used to explain how an investor holding Tonix can time the market purely based on public headlines and social activities around Tonix Pharmaceuticals Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tonix Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tonix Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Tonix Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Tonix Pharmaceuticals.
Far too much social signal, news, headlines, and media speculation about Tonix Pharmaceuticals that are available to investors today. That information is available publicly through Tonix media outlets and privately through word of mouth or via Tonix internal channels. However, regardless of the origin, that massive amount of Tonix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tonix Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tonix Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tonix Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tonix Pharmaceuticals alpha.
Tonix Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access | 01/08/2025 |
2 | Acquisition by Saenger Bradley of 540000 shares of Tonix Pharmaceuticals at 1.53 subject to Rule 16b-3 | 01/29/2025 |
3 | Tonix Pharmaceuticals to Participate in the 2025 BIO CEO Investor Conference | 02/05/2025 |
4 | Insider Trading | 02/18/2025 |
5 | Acquisition by Fogarty Siobhan of 13500 shares of Tonix Pharmaceuticals at 10.0625 subject to Rule 16b-3 | 02/25/2025 |
6 | A 41 percent Surge This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market | 03/06/2025 |
7 | Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium for Development of TNX-801, the Companys Single-Dose Mpox and Smallpox Vaccine Candidat... | 03/10/2025 |
8 | Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th | 03/11/2025 |
9 | Tonixs TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs Autoimmune Diseases Also a Target | 03/12/2025 |
10 | STAT Up and down the ladder The latest comings and goings | 03/14/2025 |
11 | Tonix Pharmaceuticals GAAP EPS of -9.77 misses by 3.54, revenue of 2.58M misses by 0.77M | 03/18/2025 |
12 | As Mpox Cases Spread Around the World, Tonix Pharmaceuticals Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread | 03/20/2025 |
13 | Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retails Feeling Bullish - MSN | 03/21/2025 |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.